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Abstract In human fibroblasts, replicative senescence, telomere
length and donor age are closely interrelated. We analyzed these
relationships for fibroblast strains from 14 healthy human donors
in the age range of 28^90 years. In vitro replicative capacity was
correlated more closely with donor age than with telomere length
ex vivo, especially for healthy donors. Telomere length at
senescence was as variable as at cell explantation and increased
with donor age. The data suggest a donor-specific, age-dependent
regulation of the telomere length threshold that triggers
senescence in human fibroblasts. ß 2002 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Since its ¢rst formal description [1], replicative senescence
of untransformed human cells has been regarded as an impor-
tant model of, and a possible contributing factor to, ageing
(for review, see [2]). One major argument in favor of such a
role was the negative correlation between donor age and rep-
licative potential in vitro. While such a correlation was dem-
onstrated for di¡erent cell types including, for instance, adre-
nocortical cells [3], a careful re-evaluation failed to con¢rm it
for human ¢broblasts from healthy donors [4]. However, telo-
mere lengths were not recorded in this study.
There is good evidence that it is the shortening of telomeres
with each round of DNA replication, which serves as ‘replic-
ometer’ and signals irreversible cell cycle arrest, i.e. senes-
cence, after reaching a certain threshold (for review, see [5].
Thus, the average length of all telomeres at a given population
doubling level (PDL) has been shown to be a good predictor
of the remaining replicative capacity of this culture [3,6,7].
However, the simple relation between telomere length and
Hay£ick limit becomes more complicated by a number of
factors: (i) It is not clear whether the length threshold that
signals senescence applies to the shortest telomere, a group of
(short) telomeres or all telomeres in a cell. While some recent
data indicate that maintenance of the shortest telomere(s) is
most important for cell growth and viability [8,9], it has also
been shown that very short telomeres can exist on some chro-
mosomes long before senescence and that average telomere
length correlates better with the remaining proliferative ca-
pacity than the length of any single telomere [7]. (ii) Probably,
not only telomere length but also other factors, which in£u-
ence the probability of unscheduled opening of the telomeric
loop [10], might trigger a senescence signal. Those factors
could be the available amounts of loop-stabilizing proteins
TRF1 and TRF2 or the presence of telomeric strand breaks
[11]. (iii) The threshold telomere length at senescence might
not be constant between cell strains or even between experi-
ments [12]. In fact, one study suggested a negative correlation
between donor age and ¢broblast telomere length at senes-
cence [13]. (iv) The rate of telomere shortening varies between
strains from di¡erent donors. Oxidative stress [12] and, espe-
cially, di¡erences in the antioxidant defence capacity between
strains [14] are the most important causes for this variation.
To better understand how donor age and telomere length at
explantation and at senescence in£uence the Hay£ick limit, we
analyzed the multiple correlations between these parameters
for ¢broblast strains from human donors between 28 and 91
years of age. The Hay£ick limit for ¢broblasts derived from
the skin of healthy donors correlated signi¢cantly with donor
age, but not with telomere length ex vivo. Telomere length at
senescence was highly variable and increased with donor age.
The data suggest a donor-speci¢c, age-dependent regulation
of the telomere length threshold that triggers senescence in
human ¢broblasts.
2. Materials and methods
2.1. Cell culture
Fibroblast cultures were established from skin biopsies from the
unexposed part of the left upper arm from 14 individuals (age range
28^91 years) after informed consent was obtained. All donors were
non-demented and free of severe cardio- or cerebrovascular condi-
tions. Cultures from 10 donors were grown until close to senescence.
Cells were grown in Dulbecco’s modi¢ed Eagle’s medium plus 10%
fetal calf serum under an atmosphere of 20% oxygen, 5% CO2. In
addition, six skin ¢broblast cultures and one culture from fetal lung
¢broblasts (MRC-5) were grown for 6 weeks under 40% normobaric
hyperoxia in a three-gas incubator (Nuaire), returned to normoxia
afterwards and grown under normoxia until senescence. Cells were
always passaged before reaching con£uence and counted at each pas-
sage in triplicate using a hematocytometer. To establish a prolifera-
tion record independent of the di¡erences in the starting material,
growth curves were extrapolated back to day 0 and the PDL at that
day was set to 0. The Hay£ick limit population doubling PDmax was
obtained using the condition that the culture should perform less than
one doubling in 4 weeks. To obtain error estimates from the cell
counts, the growth curve was ¢tted with a Chapman equation
PD  y0  a13e3btc
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The equation was solved for the conditions as stated above to obtain
PDmax, and the standard error of PDmax was calculated according to
the Gaussian law of error propagation.
2.2. Telomere length
For preparation of highest quality genomic DNA, cells were em-
bedded in 0.65% low-melting agarose plugs at a density of 107 cells/ml
before deproteination by proteinase K treatment [15,16]. DNA was
digested until completion with HinfI (60 U/plug; Boehringer Mann-
heim, Germany) at 37‡C. Plugs were analyzed in a 1.0% agarose gel
by pulsed ¢eld gel electrophoresis (Bio-Rad, Hercules, CA, USA).
Gels were blotted to Hybond N+-membranes and hybridized with
the telomeric probe (TTAGGG)4, conjugated directly to alkaline
phosphatase (Promega, Madison, WI, USA). A chemiluminescence
signal was recorded on ¢lm within the linear range and analyzed in
an imaging densitometer (Bio-Rad). The average telomere length was
calculated as weighted mean of the optical density as described [15].
To standardize measurements between di¡erent blots, two di¡erent
markers (1 kb ladder, and VHindIII) were used. In addition, at least
¢ve lanes per blot were used for repetition of measurements from
previous blots. Telomere length was measured at at least six di¡erent
PDL, and measurements were performed in triplicate. Telomere short-
ening rates (TSRs) per PD were calculated by linear regression. First
telomere measurements were done at PDLs between 5 and 15, and last
measurements were performed at less than 5 PDL from senescence
(with 2 exceptions). Linear extrapolation was used to obtain corrected
values for the telomere length at explantation, TRF0, and at senes-
cence, TRFs. Standard errors of these estimates were obtained from
the 5% con¢dence intervals of the regression lines.
2.3. Oxidative stress
Fibroblast cultures were grown for at least three weeks in parallel
under either normoxia (control) or 40% normobaric hyperoxia. Cells
were stained for 30 min at 37‡C in the dark with 80 WM dihydro-
chloro£uorescein-diacetate as described [17]. The intensity of dihydro-
chloro£uorescein (DCF) staining is an indicator of the intracellular
oxidative stress and was measured in a £ow cytometer (Partec, Mun-
ster, Germany) using blue excitation.
2.4. Statistical evaluation
Linear regressions were calculated in SigmaPlot 2000. SPSS for
Windows was used to calculate correlation matrices.
3. Results
While ¢broblast growth rates in culture varied between do-
nors, there was no correlation to donor age or health status.
However, growth rates were constant in each case for at least
the ¢rst 6 weeks in culture, so that numbers of proliferating
cells at day 0 could safely be extrapolated by linear regression.
These cell numbers at explantation were used to ¢x PDL0 at
day 0, and all subsequent cell counts including the estimation
of the Hay£ick limit referred to it. Cell numbers at explanta-
tion varied by up to two orders of magnitude between biop-
sies, indicating that estimates of the Hay£ick limit according
to the standard procedure (i.e. ¢xing the starting PDL at the
point when the ¢rst con£uent dish is obtained) might bear
errors of up to seven PD between strains.
Our data show a signi¢cant dependency of the Hay£ick
limit for cultured human ¢broblasts from donor age, with a
decrease of about 0.5 PD per year of age (Fig. 1, top). The
length of ¢broblast telomeres ex vivo tends to decrease with
Fig. 1. Donor age dependencies (age in years) of (top) Hay£ick limit
(PDmax), (middle) telomere length at explantation (TRF0), and (bot-
tom) telomere length at senescence (TRFs). Data are mean þ S.E.M.
Linear regressions including 5% con¢dence intervals are indicated,
and regression slopes m and signi¢cance levels P are given.
Table 1
Cellular peroxide content, growth rate and TSR under normoxia
and 40% hyperoxia in seven human ¢broblast strains
DCF £uorescence
(%)
Growth rate
(PD/wek)
TSR (bp/PD)
Normoxia 100 1.68 þ 0.12 40.9 þ 12.6
Hyperoxia 152 þ 15 0.48 þ 0.13 236.0 þ 77.6
DCF £uorescence under normoxia was set to 100%. Data are
mean þ S.E.M. from seven ¢broblast strains (MRC-5 and six do-
nors). Measurements were performed in triplicate.
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age by 17 bp/year (Fig. 1, middle), however, this decrease is
statistically not signi¢cant.
Fibroblast strains from di¡erent donors senesced not with
the same average telomere length. Rather, telomere length at
senescence increased signi¢cantly with age by 31 bp/year (Fig.
1, bottom). Accordingly, the variation of telomere length be-
tween strains at senescence was as large as at explantation
(Fig. 2). Rates of telomere shortening varied as well between
strains (Fig. 2) but this variation was not age-correlated.
To examine further the regulation of telomere length at
senescence, 7 ¢broblast strains were also grown for 6 weeks
under 40% chronic normobaric hyperoxia, and then cultivated
further on under normoxia until senescence in parallel to con-
trol cultures constantly held under normoxia. Hyperoxia in-
duces oxidative stress as indicated by an increase in DCF
£uorescence. It slows down growth and accelerates telomere
shortening (Table 1), in accordance with earlier data
[12,14,18]. After resumption of basal conditions, cell growth
and TSRs paralleled that in controls. Consequently, cultures
held under hyperoxia senesce 5^10 PD earlier (Fig. 3A). How-
ever, due to the opposite e¡ects of oxidative stress on growth
rate and TSR, hyperoxic and normoxic cultures senesce with
the same donor-speci¢c telomere length. This was true irre-
spective of whether the strain senesced with long or with short
telomeres (Fig. 3B). The notion that each strain senesces with
its own telomere length is not only true with respect to the
average telomere length. As Fig. 3B clearly shows, the length
of the shortest telomeres discernible in the Southern blot is
strain-speci¢c as well.
Fig. 2. Telomere length vs. PDL for 15 ¢broblast strains from dif-
ferent donors (including ¢ve strains derived from donors su¡ering
from stroke or dementia) grown until senescence under normoxia.
Standard errors are indicated.
Table 2
Pearson correlation matrix for the Hay£ick limit PDmax, donor age,
TSR, telomere length at explantation, TRF0, and telomere length at
senescence, TRFs, in 10 ¢broblast strains derived from healthy do-
nors
PDmax Age TSR TRF0 TRFs
PDmax 1.000 30.748 0.200 0.363 30.465
Age 1.000 30.419 30.414 0.670
TSR 1.000 0.820 30.866
TRF0 1.000 30.591
TRFs 1.000
All parameters were measured under normoxia. Coe⁄cients indicat-
ing signi¢cant correlations are printed in bold.
Fig. 3. Cell growth and telomere length under normoxia and hyper-
oxia. A: Typical growth curve. Cells were grown until senescence
under either normoxia (control, ¢lled circles) or for 6 weeks under
hyperoxia (open circles) followed by further growth under normoxia
(gray circles). B: Telomere length at senescence after growth under
normoxia (N) or under normoxia/6 weeks hyperoxia/normoxia (O).
Skin ¢broblast cultures from four di¡erent donors and one embry-
onic lung ¢broblast strain (MRC-5) are shown.
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To examine further the relative roles of donor age, TSR,
telomere length ex vivo and at senescence for the Hay£ick
limit, we calculated the correlation matrix for these parame-
ters (Table 2). In accordance with the results shown in Fig. 1,
donor age was found as the strongest predictor of the Hay-
£ick limit, followed by telomere length at senescence, while
the correlation to telomere length at explantation was not
signi¢cant at the 5% level. While TSR did correlate strongly
to telomere length, it did not at all to the Hay£ick limit.
4. Discussion
According to our data, donor age is the strongest predictor
of the replicative capacity of human ¢broblasts. While this is
in favor of the concept of an age-dependent decrease of rep-
licative potential, it is not in accordance with results of a
recent large study [4], which could not detect a signi¢cant
negative correlation between replicative potential and donor
age for healthy adult donors. Although sample size was small
in our study, we believe that taking into account the cell
number at explantation for the assignment of the PDL greatly
improves the reliability of our results.
Studying ¢broblast strains from 31 donors of unreported
health status, Allsopp et al. [6] found the strongest correlation
between replicative capacity and ex vivo telomere length and
suggested telomere loss during proliferation in vivo as the
major predictor of the lower in vitro replicative capacity of
¢broblasts from old donors. We cannot con¢rm this. Exam-
ining ¢broblast strains from healthy donors, and estimating
telomere length at explantation, we did not ¢nd signi¢cant
correlations to either replicative capacity or donor age (Table
2). However, if ¢broblasts from ¢ve elderly patients with
stroke or probable vascular dementia were included (age
range 64^91 years, median 84 years), correlations between
telomere length at explantation and either Hay£ick limit or
donor age became signi¢cant ([14] and data not shown). We
have shown earlier that lymphocyte telomeres from patients
with vascular dementia were signi¢cantly shorter than those in
age-matched healthy controls, and that there was a strong
intraindividual correlation between telomere lengths in lym-
phocytes and ¢broblasts [14]. Shorter telomeres were also
found in lymphocytes from atherosclerotic patients in a like-
wise small study [19]. Abundant in vitro data suggest that
shorter telomeres in cells from diseased donors might not
simply be the result of faster cell cycling, but might be due
to oxidative stress-induced higher rates of telomere shortening
per cell division [14].
We found that neither the average telomere length, nor the
length of the shortest telomeres at senescence was constant
between strains. On the contrary, telomere length varied be-
tween strains at senescence at least as much as at explanta-
tion. Moreover, our data suggest that donor age determines
the threshold telomere length that signals senescence (Table
2). Di¡erences between telomere lengths at senescence were
also found by comparing ¢broblast strains from two infant
and two adult donors [13]. The threshold at which (average or
shortest) telomere length signals senescence is set di¡erently
for each donor. This threshold is not shifted by a period of
increased oxidative stress, which accelerates telomere shorten-
ing and shortens the replicative lifespan (Fig. 3A,B and [18]).
The same might not be true under chronically diminished oxi-
dative stress since chronic antioxidant treatment of MRC-5
¢broblasts elongated the replicative lifespan, but slowed telo-
mere shortening even further, so that treated cells senesced
with longer telomeres [12].
Our data suggest that the age-dependency of the Hay£ick
limit can partially be explained by an increase of the telomere
length at senescence with donor age (Fig. 1, bottom). A cause
for this age-dependent shift has not been established yet.
However, it has been suggested that insu⁄cient stability of
the telomeric loop [10], resulting in unscheduled loop opening
and exposure of the G-rich telomeric single-stranded overhang
to the nucleoplasm, triggers replicative senescence in telomer-
ase-negative cells [11]. Telomeric single-stranded G-rich DNA
is a strong inducer of a p53-dependent senescence-like cell
cycle arrest [20]. At least one loop-stabilizing protein, i.e.
TRF2 [21], increases in abundance as human ¢broblasts reach
senescence [13]. It is not known yet whether the expression of
such proteins is regulated in an age-dependent fashion.
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